Expertise in
20
conditions

Dr. Camilo A. Jimenez

Endocrinology
UT MD Anderson Cancer Center
210 Ashville Ave # 408, 
Cary, NC 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
20
conditions
UT MD Anderson Cancer Center
210 Ashville Ave # 408, 
Cary, NC 

Overview

Camilo Jimenez is an Endocrinologist practicing medicine in Cary, North Carolina.

Dr. Jimenez is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Pheochromocytoma, Adrenal Cancer, Neuroendocrine Tumor, Adrenocortical Carcinoma, and Thyroidectomy.

He is actively involved in clinical research, co-authoring 124 peer reviewed articles and participating in 3 clinical trials. Dr. Jimenez is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UT MD Anderson Cancer Center
210 Ashville Ave # 408, Cary, NC 27518

Additional Areas of Focus

Dr. Jimenez has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
Enrollment Status: Terminated
Publish Date: January 30, 2026
Intervention Type: Biological
Study Drugs: EO2041, Nivolumab
Study Phase: Phase 1/Phase 2
A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas
A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Drug, Other
Study Drug: Cabozantinib S-malate
Study Phase: Phase 2
A Phase II Study to Evaluate the Effects of 177Lu-DOTATATE in Patients With Unresectable and Progressive Rare Metastatic Endocrine Carcinomas: Medullary Thyroid Cancer, Parathyroid Carcinoma, Pituitary Carcinoma, and Malignant Pheochromocytoma/Paraganglioma
A Phase II Study to Evaluate the Effects of 177Lu-DOTATATE in Patients With Unresectable and Progressive Rare Metastatic Endocrine Carcinomas: Medullary Thyroid Cancer, Parathyroid Carcinoma, Pituitary Carcinoma, and Malignant Pheochromocytoma/Paraganglioma
Enrollment Status: Withdrawn
Publish Date: September 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

124 Total Publications

Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy.
Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: June 15, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Ramona Dadu
Endocrinology
Expertise in
17
conditions
Dr. Ramona Dadu
Endocrinology
Referral required
Before you request

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (0.1 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ramona Dadu is an Endocrinologist practicing medicine in Cary, North Carolina. Dr. Dadu is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Thyroidectomy. Dr. Dadu is currently accepting new patients.

Expertise in
12
conditions
Dr. Robert F. Gagel
Endocrinology
Expertise in
12
conditions
Dr. Robert F. Gagel
Endocrinology
Referral required
Before you request

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (0.1 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Gagel is an Endocrinologist practicing medicine in Cary, North Carolina. Dr. Gagel is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Medullary Thyroid Carcinoma, Thyroid Cancer, Multiple Endocrine Neoplasia Type 2, Follicular Thyroid Cancer, and Thyroidectomy. Dr. Gagel is currently accepting new patients.

Expertise in
24
conditions
Dr. Thomas J. Weber
Endocrinology
Expertise in
24
conditions
Dr. Thomas J. Weber
Endocrinology
Referral required
Before you request

Duke Endocrinology Clinic - Clinic 1A

30 Duke Medicine Cir, 
Durham, NC 
 (21.0 miles away)
919-668-5360
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Weber is an Endocrinologist practicing medicine in Durham, North Carolina. Dr. Weber is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hypophosphatemia, Rickets, X-Linked Hypophosphatemia, Malnutrition, and Parathyroidectomy. Dr. Weber is board certified in American Board Of Internal Med, Endocrinology, Diabetes & Meta. Dr. Weber is currently accepting new patients.

Frequently Asked Questions about Dr. Camilo A. Jimenez

How do I make an appointment with Dr. Camilo A. Jimenez?

You can book an appointment with Dr. Camilo A. Jimenez by calling their office at 713-792-6161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Camilo A. Jimenez a top-rated expert for Pheochromocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Camilo A. Jimenez is classified as an Elite expert for Pheochromocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Camilo A. Jimenez specialize in?

While Dr. Camilo A. Jimenez is a Endocrinology, they have specific expertise in Pheochromocytoma, Adrenal Cancer, and Neuroendocrine Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Camilo A. Jimenez participate in research or clinical trials?

Yes. Dr. Camilo A. Jimenez has published 124 articles and abstracts on conditions like Pheochromocytoma. You can view a list of Dr. Camilo A. Jimenez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Camilo A. Jimenez accept my insurance?

Dr. Camilo A. Jimenez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-792-6161 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jimenez's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 7 Advanced Conditions
View All 52 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile